{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:56:15Z","timestamp":1793145375469,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaad.2022.10.031","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:20:23Z","timestamp":1666236023000},"page":"388-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story"],"prefix":"10.1016","volume":"88","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2022.10.031_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000067817","article-title":"Epidemiology of acne","volume":"206","author":"Dreno","year":"2003","journal-title":"Dermatology"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2022.10.031_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjd.13462","article-title":"A global perspective on the epidemiology of acne","volume":"172","author":"Tan","year":"2015","journal-title":"Br J Dermatol"},{"issue":"9859","key":"10.1016\/j.jaad.2022.10.031_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jaad.2022.10.031_bib4","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/jocd.13765","article-title":"Psychodermatology of acne: psychological aspects and effects of acne vulgaris","volume":"20","author":"Stamu-O\u2019Brien","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.031_bib5","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1111\/bjd.16099","article-title":"Risk of depression among patients with acne in the U.K.: a population-based cohort study","volume":"178","author":"Vallerand","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jid.2010.264","article-title":"Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study","volume":"131","author":"Halvorsen","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.031_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.10r05993","article-title":"Retinoic acid and affective disorders: the evidence for an association","volume":"73","author":"Bremner","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.031_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Dermatoendocrinol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40257-020-00560-w","article-title":"Oral antibiotics for acne","volume":"22","author":"Patel","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.36849\/JDD.5559","article-title":"Differences in depression and distress between acne patients on isotretinoin vs oral antibiotics","volume":"20","author":"Hekmatjah","year":"2021","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.10.031_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis","volume":"76","author":"Huang","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.031_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021549","article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.jaad.2022.10.031_bib13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.10.031_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2008.03.005","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"26","author":"Marqueling","year":"2007","journal-title":"Semin Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.jaad.2022.10.031_bib15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A comparison of 12 algorithms for matching on the propensity score","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(83)80154-6","article-title":"Depression--a side effect of 13-cis-retinoic acid therapy","volume":"9","author":"Hetzen","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.031_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1067\/S0190-9622(03)02087-5","article-title":"Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis","volume":"49","author":"Hersom","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2022.10.031_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.031_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.10.031_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2340\/00015555-1638","article-title":"Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin","volume":"93","author":"Marron","year":"2013","journal-title":"Acta Dermato Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.031_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5498\/wjp.v6.i1.136","article-title":"Isotretinoin was not associated with depression or anxiety: a twelve-week study","volume":"6","author":"Suarez","year":"2016","journal-title":"World J Psychiatry"},{"issue":"6","key":"10.1016\/j.jaad.2022.10.031_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jdv.16005","article-title":"Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010-2014 French Health Insurance Data","volume":"34","author":"Droitcourt","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.031_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40272-019-00340-y","article-title":"Comparison of quality of life, depression, anxiety, suicide, social anxiety and obsessive-compulsive symptoms between adolescents with acne receiving isotretinoin and antibiotics: a prospective, non-randomised, open-label study","volume":"21","author":"Erdo\u011fan","year":"2019","journal-title":"Paediatr Drugs"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.031_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/ije\/dyz093","article-title":"Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study","volume":"48","author":"Droitcourt","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"7782","key":"10.1016\/j.jaad.2022.10.031_bib25","first-page":"1090","article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study","volume":"341","author":"Sundstr\u00f6m","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12795","article-title":"Does isotretinoin cause depression and anxiety in acne patients?","volume":"32","author":"Metekoglu","year":"2019","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.jaad.2022.10.031_bib27","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1111\/jdv.14139","article-title":"No evidence for increased anxiety in acne patients treated with isotretinoin","volume":"31","author":"Huang","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2022.10.031_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","article-title":"Psychiatric reactions to isotretinoin in patients with bipolar disorder","volume":"122","author":"Schaffer","year":"2010","journal-title":"J affective Disord"},{"key":"10.1016\/j.jaad.2022.10.031_bib29","first-page":"8853167","article-title":"Abba-Aji A. Isotretinoin-induced delusional disorder, somatic subtype","volume":"2020","author":"Jensen","year":"2020","journal-title":"Case Rep Dermatol Med"},{"issue":"1","key":"10.1016\/j.jaad.2022.10.031_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0019-5154.174091","article-title":"A case report of isotretinoin-induced manic psychosis","volume":"61","author":"Lucca","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2022.10.031_bib31","article-title":"Isotretinoin-induced psychotic episode in a 17-year-old adolescent male","volume":"8","author":"Elhusein","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"issue":"5","key":"10.1016\/j.jaad.2022.10.031_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.jaad.2022.10.031_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2007.07.001","article-title":"The neurobiology of retinoic acid in affective disorders","volume":"32","author":"Bremner","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222029231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222029231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:09:29Z","timestamp":1759273769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222029231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0190962222029231"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.10.031","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}